Celator Pharmaceuticals Corp.

Celator Pharmaceuticals Corp., headquartered in California, currently does not report specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Jazz Pharmaceuticals plc, which may influence its climate commitments and reporting practices.

As of now, Celator Pharmaceuticals has not established any documented reduction targets or initiatives related to carbon emissions. The absence of specific targets suggests that the company may still be in the early stages of developing a comprehensive climate strategy.

Given its affiliation with Jazz Pharmaceuticals, emissions data and climate initiatives may be cascaded from this parent company. However, no specific emissions data or reduction targets from Jazz Pharmaceuticals plc have been provided in this context.

In summary, while Celator Pharmaceuticals Corp. is part of a larger corporate family that may have climate commitments, it currently lacks specific emissions data and reduction initiatives of its own.